Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients

NCT01917630 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Celiac Disease

Interventions

DRUG: ALV003
DRUG: placebo

Sponsor

Alvine Pharmaceuticals Inc.